The Science behind
better gut health,
in Asia, for Asia.
AMILI is the #1 precision gut microbiome company in Southeast Asia, based in Singapore. AMILI hosts Southeast Asia’s first and only gut microbiome transplant bank and the world’s largest multi-ethnic Asian gut microbiome database. Our precision-driven, end-to-end platform captures unparalleled insights into gut microbiome abundance, functionality, and its impact on health.
Research Partners
We Work With
News
Why AMILI is the
Future of Gut Health
Who are we?
AMILI is the #1 precision gut microbiome company in Southeast Asia, based in Singapore. AMILI hosts Southeast Asia’s first and only gut microbiome transplant bank and the world’s largest multi-ethnic Asian gut microbiome database. Our precision-driven, end-to-end platform captures unparalleled insights into gut microbiome abundance, functionality, and its impact on health.
What do we do?
AMILI is a Gut Health Data insights and analytics platform. By operating end-to-end, AMILI captures richer more accurate insights into gut microbiome abundance, functionality and health impact. AMILI consists of 3 components, AMILI Analytics, AMILI Health, and AMILI Biosciences.
AMILI Analytics works with industry partners to formulate microbiome-enabled personalised products and services, AMILI Health sells our proprietary Gut Health Test Kits and Probiotics, and AMILI Biosciences creates FDA and HAS approved therapeutics and diagnostics.
Advancing Human Health Through Microbiome Science
.svg)